EP
PCVX icon

Edgestream Partners’s Vaxcyte PCVX Stock Holding History

Edgestream Partners’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.62M Buy
+131,115
New +$7.12M 0.23% 125
2025
Q4 		– Sell
-30,771
Closed -$1.11M – 1098
2025
Q3 		$1.11M Sell
30,771
-18,747
-38% -$621K 0.03% 614
2025
Q2 		$1.61M Buy
+49,518
New +$1.62M 0.04% 567
2025
Q1 		– Sell
-3,586
Closed -$294K – 1000
2024
Q4 		$294K Buy
+3,586
New +$356K 0.01% 762
2024
Q1 		– Sell
-17,706
Closed -$1.11M – 970
2023
Q4 		$1.11M Buy
+17,706
New +$920K 0.08% 411

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Edgestream Partners's PCVX Position: Q2 2026 in Review

Edgestream Partners opened a new position in Vaxcyte (PCVX) in Q2 2026: 131,115 shares worth $7.62M. The stake represents 0.23% of the portfolio and ranks #125 among its holdings. This is a return to the name: Edgestream Partners previously reported a position in PCVX as recently as Q3 2025.

Edgestream Partners first reported a position in PCVX in Q4 2023 and has held it in 5 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Edgestream Partners held 131,115 shares of Vaxcyte worth $7.62M as of Q2 2026.
  • Vaxcyte was a new Edgestream Partners position in Q2 2026.
  • Vaxcyte made up 0.23% of Edgestream Partners's portfolio in Q2 2026, its #125 holding.
  • Edgestream Partners first reported a position in Vaxcyte in Q4 2023 and has held it in 5 quarters since.
  • 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.